Doulathunnisa Jaffar Ali

Statistics

Publications

Citations

858

H-Index

Active since

2017

Affiliations

State Key Laboratory of Digital Medical Engineering(Current)

Southeast University

Nanjing Medical University

Texas A&M Health Science Center

BioElectronics (United States)

Doulathunnisa Jaffar Ali is an author at State Key Laboratory of Digital Medical Engineering specializing in oncology, molecular oncology, and cancer cell signaling.

Publications per year

2017–2023

Publications

Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer

Gaofeng Liang, Yanliang Zhu, Doulathunnisa Jaffar Ali et al. · Journal of Nanobiotechnology · 2020 · 685 citations · Full text

Medicine, Oncology, Pharmacology +17

Exosomes Transfer Among Different Species Cells and Mediating miRNAs Delivery

Yueyuan Zhou, Tian Tian, Yanliang Zhu et al. · Journal of Cellular Biochemistry · 2017 · 47 citations

Life Sciences, Cell Biology, Molecular Biology +14

Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib

Cong He, Doulathunnisa Jaffar Ali, Huantian Xu et al. · Experimental Cell Research · 2020 · 46 citations

Life Sciences, Biotechnology, Oncology +14

Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells

Cong He, Doulathunnisa Jaffar Ali, Yuhua Qi et al. · Journal of Nanobiotechnology · 2023 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells

Cong He, Doulathunnisa Jaffar Ali, Yumin Li et al. · PeerJ · 2020 · 16 citations · Full text

Pharmacy, Biotechnology, Oncology +17

1–5 of 7